Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
University of Pavia
Pavía, ItaliaPublications in collaboration with researchers from University of Pavia (29)
2024
-
Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy
Radiotherapy and Oncology, Vol. 198
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
-
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Blood cancer discovery, Vol. 5, Núm. 3, pp. 146-152
2023
-
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
-
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
The Lancet. Oncology, Vol. 24, Núm. 7, pp. e293-e311
-
Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis
Seminars in Hematology
2022
-
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis
Leukemia, Vol. 36, Núm. 8, pp. 2076-2085
-
Deconvolution of the hematopoietic stem cell microenvironment reveals a high degree of specialization and conservation
iScience, Vol. 25, Núm. 5
-
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
ESMO Open, Vol. 7, Núm. 2
-
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
European Journal of Haematology, Vol. 108, Núm. 1, pp. 73-83
-
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
BJS Open, Vol. 6, Núm. 1
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis
Blood Cancer Journal, Vol. 11, Núm. 2
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Blood Cancer Journal, Vol. 11, Núm. 12
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood, Vol. 138, Núm. 17, pp. 1583-1589
2020
-
Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: An analysis from the European Society for Blood and Marrow Transplantation
ESMO Open, Vol. 5, Núm. 5
-
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Blood Cancer Journal, Vol. 10, Núm. 10